Zhe-ran Liu1 article listing Zhe-ran Liu in Nature Communications, indexed by Paperzzz from Crossref and OSF.Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial Nature Communications